Drugs that contain Ethinyl Estradiol; Levonorgestrel

1. Drug name - BALCOLTRA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7838042 AVION PHARMS Hypoallergenic metal amino acid chelates and metal amino acid chelate-containing compositions
Jun, 2027

(4 years from now)

Treatment: NA

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
0.02MG;0.1MG TABLET;ORAL Prescription

2. Drug name - LOSEASONIQUE

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7615545 TEVA BRANDED PHARM Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology Jun, 2023

(8 months from now)

US7858605 TEVA BRANDED PHARM Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology Jun, 2023

(8 months from now)

US7855190 TEVA BRANDED PHARM Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration Dec, 2028

(6 years from now)

Treatment: Prevention of pregnancy

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
0.02MG,0.1MG;0.01MG,N/A TABLET;ORAL Prescription

3. Drug name - QUARTETTE

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8450299 TEVA BRANDED PHARM Methods of hormonal treatment utilizing ascending-dose extended cycle regimens Oct, 2025

(3 years from now)

US8415332 TEVA BRANDED PHARM Methods of hormonal treatment utilizing ascending-dose extended cycle regimens Mar, 2029

(6 years from now)

Treatment: Prevention of pregnancy

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
0.02MG,0.15MG;0.025MG,0.15MG;0.03MG,0.15MG;0.01MG,N/A TABLET;ORAL Prescription

4. Drug name - SEASONIQUE

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7615545 TEVA BRANDED PHARM Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology Jun, 2023

(8 months from now)

US7858605 TEVA BRANDED PHARM Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology Jun, 2023

(8 months from now)

US7320969 TEVA BRANDED PHARM Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology Jan, 2024

(1 year, 4 months from now)

US7855190 TEVA BRANDED PHARM Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration Dec, 2028

(6 years from now)

Treatment: Prevention of pregnancy; Prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
0.03MG,0.01MG;0.15MG,N/A TABLET;ORAL Prescription

5. Drug name - TWIRLA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8747888 AGILE Dermal delivery device with in situ seal Jul, 2028

(5 years from now)

US9050348 AGILE Dermal delivery device Jul, 2028

(5 years from now)

US8246978 AGILE Dermal delivery device with reduced loss of its volatile components Aug, 2028

(5 years from now)

Treatment: NA

Dosage: SYSTEM;TRANSDERMAL

More Information on Dosage
Strength Dosage Availability
0.03MG/24HR;0.12MG/24HR SYSTEM;TRANSDERMAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.